35th week of 2020 patent applcation highlights part 25 |
Patent application number | Title | Published |
20200270297 | MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR | 2020-08-27 |
20200270298 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | 2020-08-27 |
20200270299 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | 2020-08-27 |
20200270300 | Aminosteroids for the Treatment of a PTP1B Associated Disease | 2020-08-27 |
20200270301 | METHOD FOR EXTENDING HALF-LIFE OF PROTEIN | 2020-08-27 |
20200270302 | METHOD AND COMPOSITION FOR HYDROLYZING EGGSHELL MEMBRANE | 2020-08-27 |
20200270303 | MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS | 2020-08-27 |
20200270305 | GENE EXPRESSION INHIBITORS | 2020-08-27 |
20200270306 | PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES | 2020-08-27 |
20200270307 | RATIONALLY-DESIGNED SYNTHETIC PEPTIDE SHUTTLE AGENTS FOR DELIVERING POLYPEPTIDE CARGOS FROM AN EXTRACELLULAR SPACE TO THE CYTOSOL AND/OR NUCLEUS OF A TARGET EUKARYOTIC CELL, USES THEREOF, METHODS AND KITS RELATING TO SAME | 2020-08-27 |
20200270308 | CANCER TREATMENT DRUG | 2020-08-27 |
20200270309 | MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF | 2020-08-27 |
20200270310 | MAFG AS A POTENTIAL THERAPEUTIC TARGET TO RESTORE CHEMOSENSITIVITY IN PLATINUM-RESISTANT CANCER CELLS | 2020-08-27 |
20200270311 | SUBSTITUTED UREA DEPSIPEPTIDE ANALOGS AS ACTIVATORS OF THE CLPP ENDOPEPTIDASE | 2020-08-27 |
20200270312 | MODULAR DNA-BINDING DOMAINS AND METHODS OF USE | 2020-08-27 |
20200270313 | COMPOSITIONS AND METHODS FOR SUPPRESSION OF INHIBITOR FORMATION AGAINST COAGULATION FACTORS IN HEMOPHILIA PATIENTS | 2020-08-27 |
20200270314 | Metabolite Production in Endophytes | 2020-08-27 |
20200270315 | COMPOSITIONS FOR IMPROVING CELLS AND ORGANISMS | 2020-08-27 |
20200270316 | Silk Alcohol Formulations | 2020-08-27 |
20200270317 | POLYPEPTIDES WITH PHASE TRANSITION, TRIBLOCK POLYPEPTIDES OF THE POLYPEPTIDE-CALMODULIN-POLYPEPTIDE WITH MULTI-STIMULI RESPONSIVENESS, HYDROGEL OF THE TRIBLOCK POLYPEPTIDES, AND ITS USES | 2020-08-27 |
20200270318 | GLYCOSYLATED PEPTIDES WITH PSEUDOPROLINE RESIDUES AND HAVING ENHANCED HALF-LIVES AND ABILITY TO CROSS THE BLOOD BRAIN BARRIER | 2020-08-27 |
20200270319 | TREATMENT OF DAMAGED NERVE WITH PTEN INHIBITOR | 2020-08-27 |
20200270320 | Thermostable FGF2 Polypeptide, Use Thereof | 2020-08-27 |
20200270321 | ANTIGEN BINDING MOLECULES COMPRISING A TRIMERIC TNF FAMILY LIGAND | 2020-08-27 |
20200270322 | NOVEL INTERLEUKIN 4 IMMUNOCONJUGATES | 2020-08-27 |
20200270323 | INTERLEUKIN 15 FUSION PROTEIN FOR TUMOR TARGETING THERAPY | 2020-08-27 |
20200270324 | SIRP POLYPEPTIDE COMPOSITIONS AND METHODS OF USE | 2020-08-27 |
20200270325 | LONG-ACTING CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS | 2020-08-27 |
20200270326 | CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR AND USES THEREOF | 2020-08-27 |
20200270327 | NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR | 2020-08-27 |
20200270328 | METHODS OF TREATMENTS USING CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR | 2020-08-27 |
20200270329 | T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3 | 2020-08-27 |
20200270330 | TRIFUNCTIONAL T CELL-ANTIGEN COUPLER AND METHODS AND USES THEREOF | 2020-08-27 |
20200270331 | IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION | 2020-08-27 |
20200270332 | Means and Methods for Treating and Diagnosing Fibrosis or Fibrosis-associated Diseases | 2020-08-27 |
20200270333 | PEGYLATED ENDOSTATIN ANALOGUE AND APPLICATION THEREOF | 2020-08-27 |
20200270334 | ANTIBODY-CYTOKINE ENGRAFTED PROTEINS AND METHODS OF USE IN THE TREATMENT OF CANCER | 2020-08-27 |
20200270335 | DKK2 CYSTEINE RICH DOMAIN 2 CONTAINING PROTEINS AND USES THEREOF | 2020-08-27 |
20200270336 | STABLE PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY | 2020-08-27 |
20200270337 | Pharmaceutical Use of FAM19A5 Involved in Regulating Gliogenesis | 2020-08-27 |
20200270338 | EXPRESSION CONSTRUCTS, HOST CELLS, AND METHODS FOR PRODUCING INSULIN | 2020-08-27 |
20200270339 | ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF | 2020-08-27 |
20200270340 | TREATMENT OF KIDNEY INJURY | 2020-08-27 |
20200270341 | Compositions and Methods for Treating Cancer | 2020-08-27 |
20200270342 | HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta) | 2020-08-27 |
20200270343 | ANTI-VSIG10 ANTIBODIES AND METHODS OF USE | 2020-08-27 |
20200270344 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY GASTROINTESTINAL DISORDERS | 2020-08-27 |
20200270345 | Antibodies specific to CD47 and PD-L1 | 2020-08-27 |
20200270346 | ANTI-TIGIT ANTIBODIES | 2020-08-27 |
20200270347 | ANTIBODIES BINDING TO CD3 | 2020-08-27 |
20200270348 | ANTI-PD-L1 ANTIBODIES AND DIAGNOSTIC USES THEREOF | 2020-08-27 |
20200270349 | METHODS OF TREATMENT BY TARGETING VCAM1 AND MAEA | 2020-08-27 |
20200270350 | ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS OF USE THEREOF | 2020-08-27 |
20200270351 | Combination Therapies and Patient Stratification with Bispecific Anti-EGFR/c-Met Antibodies | 2020-08-27 |
20200270352 | IGF-1R ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER | 2020-08-27 |
20200270353 | COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF | 2020-08-27 |
20200270354 | COMBINATION TREATMENT FOR CANCER | 2020-08-27 |
20200270355 | ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES | 2020-08-27 |
20200270356 | ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF | 2020-08-27 |
20200270357 | Monospecific and Bispecific Proteins with Immune Checkpoint Regulation for Cancer Therapy | 2020-08-27 |
20200270358 | AFUCOSYLATED MONOCLONAL ANTIBODY | 2020-08-27 |
20200270359 | BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF | 2020-08-27 |
20200270360 | ANTI-TM4SF1 ANTIBODIES AND METHODS OF USING SAME | 2020-08-27 |
20200270361 | CD37-BINDING MOLECULES AND IMMUNOCONJUGATES THEREOF | 2020-08-27 |
20200270362 | MSLN TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE | 2020-08-27 |
20200270363 | ANTIBODY HAVING ENHANCED ACTIVITY, AND METHOD FOR MODIFYING SAME | 2020-08-27 |
20200270364 | ANTI-COAGULATION FACTOR XI ANTIBODIES | 2020-08-27 |
20200270365 | PCSK9 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND MEDICAL USES THEREOF | 2020-08-27 |
20200270366 | BISPECIFIC ANTIBODIES AGAINST HER2 AND CD3 | 2020-08-27 |
20200270367 | FC-REGION VARIANTS WITH MODIFIED FCRN-BINDING AND METHODS OF USE | 2020-08-27 |
20200270368 | CELLULOSE MIXED ESTER AND MOLDED ARTICLE OF SAME | 2020-08-27 |
20200270369 | METHOD FOR PRODUCING CELLULOSE NANOFIBERS | 2020-08-27 |
20200270370 | METHOD FOR PREPARING AN INHIBITED STARCH | 2020-08-27 |
20200270371 | AMPHIPHILIC POLYMER AND MANUFACTURING METHOD THEREOF, USE OF AMPHIPHILIC POLYMER AS CONTACT LENS MATERIAL, CONTACT LENS MATERIAL INCLUDING AMPHIPHILIC POLYMER | 2020-08-27 |
20200270372 | PENTOSAN POLYSULFATE AND METHOD FOR PRODUCING PENTOSAN POLYSULFATE | 2020-08-27 |
20200270373 | PROCESS FOR TRANSITIONING BETWEEN INCOMPATIBLE CATALYSTS | 2020-08-27 |
20200270374 | CONTINUOUS AND MODULAR PROCESS FOR PRODUCING WATER-REDISPERSIBLE POLYMER POWDER COMPOSITIONS | 2020-08-27 |
20200270375 | Deactivation Methods for Active Components from Gas Phase Polyolefin Polymerization Processes | 2020-08-27 |
20200270376 | BIS-PHENYL-PHENOXY POLYOLEFIN CATALYSTS HAVING TWO METHYLENETRIALKYLSILICON LIGANDS ON THE METAL FOR IMPROVED SOLUBILITY | 2020-08-27 |
20200270377 | METHOD FOR PRODUCING BUTENE POLYMER | 2020-08-27 |
20200270378 | Modifier, Modified And Conjugated Diene-Based Polymer And Rubber Composition Including The Same | 2020-08-27 |
20200270379 | Resin Composition and Molding Method Thereof | 2020-08-27 |
20200270380 | AQUEOUS ETHYLENE RESIN DISPERSION AND AQUEOUS HEAT SEALING MATERIAL | 2020-08-27 |
20200270381 | Polyolefin Polymer Composition | 2020-08-27 |
20200270382 | CATALYST COMPOSITION FOR PREPARING ELASTIC COPOLYMER, AND METHOD FOR PREPARING ELASTIC COPOLYMER, WHICH COMPRISES ETHYLENE AND ALPHA-OLEFIN OR ETHYLENE, ALPHA-OLEFIN AND UNCONJUGATED DIENE, BY USING SAME | 2020-08-27 |
20200270383 | POLYETHYLENE FOR PIPES | 2020-08-27 |
20200270384 | CURABLE COMPOSITION, FILM, CURED PRODUCT, AND MEDICAL MEMBER | 2020-08-27 |
20200270385 | POLY(VINYL ACETAL) RESIN COMPOSITION, ADHESIVE SHEET, INTERLAMINAR FILLING MATERIAL FOR TOUCH PANEL, AND LAMINATE | 2020-08-27 |
20200270386 | MOLDING MATERIAL AND METHOD FOR PRODUCING RESIN MOLDED BODY USING SAME | 2020-08-27 |
20200270387 | AQUEOUS DISPERSION OF POLYMERIC COMPOSITE MICROSPHERES | 2020-08-27 |
20200270388 | A POLYURETHANE WITH DELAYED RELAXATION BEHAVIOUR FOR COMPRESSION PRODUCTS | 2020-08-27 |
20200270389 | SURFACE PROTECTING RESIN MEMBER AND LIQUID SET | 2020-08-27 |
20200270390 | TWO-COMPONENT SYSTEM FOR ELASTIC COATINGS | 2020-08-27 |
20200270391 | PROCESS FOR THE PRODUCTION OF POLYURETHANE FOAMS | 2020-08-27 |
20200270392 | COMPOSITE FOR FILM FORMATION AND FILM FORMING METHOD | 2020-08-27 |
20200270393 | HARDENER COMPOSITION | 2020-08-27 |
20200270394 | CHARGE TRANSFER SALT, ELECTRONIC DEVICE AND METHOD OF FORMING THE SAME | 2020-08-27 |
20200270395 | LOW DENSITY VOID CONTAINING FILMS | 2020-08-27 |
20200270396 | LIQUID CRYSTALLINE POLYESTER COMPOSITIONS AND METHODS | 2020-08-27 |
20200270397 | METHOD FOR PREPARING POLYAMIDE BY ANION RING-OPENING POLYMERIZATION AND POLYAMIDE PREPARED THEREBY | 2020-08-27 |